Relationship of a Donor for Bone Marrow Transplantation with Blood Diseases: A Clinical Epidemiological Study
GARI International Journal of Multidisciplinary Research · 31.05.2021
DOI: 10.63572/gari7865 ↗Kurz gefasst
Fachartikel in der Zeitschrift GARI International Journal of Multidisciplinary Research, online erschienen am 31.05.2021. Verfasst von Saniya Sadaf Khan.
Abstract (Originalsprache)
Background
Bone-marrow transplantation (BMT) remains the definitive curative therapy for many hematologic malignancies and inherited bone-marrow failure syndromes. The success of BMT depends largely on donor–recipient biological compatibility, including HLA match, blood group, donor age, and relationship. In India and other South-Asian settings, donor availability is constrained by limited registries, smaller family size, and sociocultural barriers, making the analysis of donor–disease relationships crucial for optimizing outcomes.
Objective
To determine how donor relationship and immunogenetic characteristics influence post-transplant survival and complication patterns among recipients of hematologic diseases.
Methods
A retrospective– prospective analytical cohort study was performed including 400 consecutive patients who underwent allogeneic BMT between January 2015 and December 2024 at four tertiary centers. Data were extracted from transplant registries and patient records. Key diseases included acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), aplastic anemia, lymphoma, multiple myeloma, and β-thalassemia major. Donors were categorized as matched sibling (MSD), matched unrelated (MUD), haploidentical (HAPLO), or parent–child. Outcomes measured were engraftment success, acute and chronic graft-versus-host disease (GVHD), relapse, infection, and overall survival (OS) at 12 months. Independent variables comprised donor relationship, age, gender, HLA match %, ABO compatibility, and conditioning regimen. Statistical analyses employed Kaplan–Meier survival estimation with log-rank testing, Cox proportional-hazards regression, and multivariable logistic regression for binary outcomes. Adjusted hazard ratios (aHR) and odds ratios (AOR) with 95 % confidence intervals were reported; p < .05 denoted significance.
Results
Of 400 recipients (median age = 27 years, range 3–61 years), 240 (60 %) received grafts from MSDs, 80 (20 %) from HAPLO donors, 60 (15 %) from MUDs, and 20 (5 %) from parents or children. Major indications were AML (28 %), aplastic anemia (22 %), βthalassemia (20 %), ALL (15 %), and others (15 %). Overall engraftment rate was 91.3 %, with median neutrophil recovery on day +16. Twelve-month OS was highest for MSD (82 %), intermediate for MUD (74 %), and lowest for HAPLO (62 %; log-rank p < .001). Cox regression adjusted for age, diagnosis, and conditioning intensity revealed aHR for mortality of 1.00 (reference = MSD), 1.48 (1.05–2.10) for MUD, and 1.92 (1.40–2.63) for HAPLO transplants. The risk of acute GVHD grade ≥ II was 18 % in MSD, 29 % in MUD, and 36 % in HAPLO donors (AOR 1.94, 1.31–2.88 vs MSD). ABO incompatibility independently predicted delayed engraftment (AOR 1.77, 1.09–2.86). In subgroup analysis, thalassemia patients transplanted from sibling donors < 25 years achieved 1-year event-free survival (EFS) of 89 % compared with 72 % for older sibling donors (p = .02). Interaction between donor age and cell dose significantly affected OS (p = .03).
Zitieren
APA
Khan, S. S. (2021). Relationship of a Donor for Bone Marrow Transplantation with Blood Diseases: A Clinical Epidemiological Study. GARI International Journal of Multidisciplinary Research. https://doi.org/10.63572/gari7865
Vancouver
Khan SS. Relationship of a Donor for Bone Marrow Transplantation with Blood Diseases: A Clinical Epidemiological Study. GARI International Journal of Multidisciplinary Research. 2021. doi:10.63572/gari7865
BibTeX
@article{Khan2021,
author = {Khan, Saniya Sadaf},
title = {Relationship of a Donor for Bone Marrow Transplantation with Blood Diseases: A Clinical Epidemiological Study},
journal = {GARI International Journal of Multidisciplinary Research},
year = {2021},
doi = {10.63572/gari7865}
}
EUVIMED